Search BioPortfolio:
BioPortfolio
Web
Home
Careers
Conferences
Directory
Drug Discovery
Genes
InDepth
Marketing
News
Reports
Videos
Search
Contact
Panic Disorder News and Headlines
Panic Disorder News updated every 30 minutes from thousands of internet sites.
Sign-up to BioPortfolio's Panic Disorder
news alerts
.
Site Map
>
Biotechnology News
>
Health News
> Panic Disorder
.
Treatment Planning for Panic Disorder
Consultant Live:
similar ...
Panic Disorder: Research from University of Montreal yields new findings on panic disorder
NewsRX:
similar ...
Research and Markets: New Edition of Anxiety, Phobias & Panic Disorders Clinical Guidelines for the Evaluation
Pharma Live:
similar ...
Potential Genetic Testing For Substance Abuse
Genomics & Genetics Weekly via NewsRx.com:
similar ...
Tikvah Therapeutics Signs Agreement to Develop and Commercialize Compounds to Treat Anxiety-Related Disorders
PR Newswire:
similar ...
MediciNova Announces Results From a Phase II/III Generalized Anxiety Disorder Trial With MN-305
PR Newswire:
similar ...
Lilly Submits Cymbalta Supplemental New Drug Application for Generalized Anxiety Disorder
Market Wire, Incorporated:
similar ...
Serotonin transporter gene promoter polymorphism affects paroxetine efficiency
Genomics & Genetics Weekly via NewsRx.com:
similar ...
Metabotropic glutamate II receptor agonist LY354740 ineffective in clinical trial
Pain & Central Nervous System Week via NewsRx.com:
similar ...
Lilly Plans to Submit Cymbalta(R) (duloxetine hydrochloride) New Drug Application for Generalized Anxiety Disorder
PR Newswire:
similar ...
EFFEXOR XR Approved for the Treatment of Panic Disorder
PR Newswire:
similar ...
MAO-A gene polymorphisms associated with panic attacks and GAD - Gene Polymorphisms
NewsRxGenomicsGenetics:
similar ...
Pivotal phase III trial begins for ocinaplon, an antianxiety drug candidate - Anxiety
NewsRxPainCNS:
similar ...
DOV Initiates Pivotal Phase III Trial for Ocinaplon, its Novel Anti-Anxiety Drug Candidate
PR Newswire:
similar ...
Repligen Initiates Clinical Trial of Secretin in Obsessive-Compulsive Disorder
PR Newswire:
similar ...
Forest Laboratories submits response for Lexapro for panic disorder.
CHEMICAL BUSINESS NEWSBASE - PRESS RELEASE:
similar ...
